Earnings Feed
Start Free
Home/Filings/4/0001181431-13-019224
4//SEC Filing

MEDIPHASE VENTURE PARTNERS II LP 4

Accession 0001181431-13-019224

CIK 0001373707other
View on SEC.govCompany Profile

Filed

Mar 26, 8:00 PM ET

Accepted

Mar 27, 8:15 PM ET

Size

69.0 KB

Accession

0001181431-13-019224

Insider Transaction Report

Form 4
Period: 2013-03-25
TETRAPHASE PHARMACEUTICALS INCTTPH
Mediphase Venture Partners II (Select Fund) Limited Partnership
10% Owner
Transactions
  • Conversion

    Common Stock

    2013-03-25+213,552→ 305,855 total
  • Conversion

    Common Stock

    2013-03-25+295,068→ 600,923 total
  • Conversion

    Common Stock

    2013-03-25+95,226→ 248,153 total
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−400,000→ 0 total
    → Common Stock (13,793 underlying)
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−800,000→ 0 total
    → Common Stock (27,586 underlying)
  • Conversion

    Common Stock

    2013-03-25+27,586→ 56,321 total
  • Conversion

    Common Stock

    2013-03-25+17,991→ 31,784 total
  • Conversion

    Common Stock

    2013-03-25+100,591→ 100,591 total
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−1,043,478→ 0 total
    → Common Stock (35,982 underlying)
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−3,096,509→ 0 total
    → Common Stock (106,776 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−9,101,517→ 0 total
    → Common Stock (313,845 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−8,556,982→ 0 total
    → Common Stock (295,068 underlying)
  • Conversion

    Common Stock

    2013-03-25+106,776→ 152,927 total
  • Conversion

    Common Stock

    2013-03-25+313,845→ 419,164 total
  • Purchase

    Common Stock

    2013-03-25$7.00/sh+121,428$849,996→ 540,592 total
  • Conversion

    Common Stock

    2013-03-25+73,535→ 105,319 total
  • Conversion

    Common Stock

    2013-03-25+13,793→ 13,793 total
  • Conversion

    Common Stock

    2013-03-25+13,793→ 28,160 total
  • Conversion

    Common Stock

    2013-03-25+35,982→ 92,303 total
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−400,000→ 0 total
    → Common Stock (13,793 underlying)
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−2,132,517→ 0 total
    → Common Stock (73,555 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−2,917,152→ 0 total
    → Common Stock (100,591 underlying)
  • Conversion

    Common Stock

    2013-03-25+17,991→ 46,151 total
  • Purchase

    Common Stock

    2013-03-25$7.00/sh+164,285$1,149,995→ 765,208 total
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−521,739→ 0 total
    → Common Stock (17,991 underlying)
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−521,739→ 0 total
    → Common Stock (17,991 underlying)
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−6,193,019→ 0 total
    → Common Stock (213,552 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−2,761,571→ 0 total
    → Common Stock (95,226 underlying)
Mediphase II LLC
10% Owner
Transactions
  • Conversion

    Common Stock

    2013-03-25+13,793→ 28,160 total
  • Conversion

    Common Stock

    2013-03-25+213,552→ 305,855 total
  • Conversion

    Common Stock

    2013-03-25+100,591→ 100,591 total
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−400,000→ 0 total
    → Common Stock (13,793 underlying)
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−3,096,509→ 0 total
    → Common Stock (106,776 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−9,101,517→ 0 total
    → Common Stock (313,845 underlying)
  • Conversion

    Common Stock

    2013-03-25+13,793→ 13,793 total
  • Conversion

    Common Stock

    2013-03-25+17,991→ 31,784 total
  • Conversion

    Common Stock

    2013-03-25+73,535→ 105,319 total
  • Conversion

    Common Stock

    2013-03-25+295,068→ 600,923 total
  • Purchase

    Common Stock

    2013-03-25$7.00/sh+164,285$1,149,995→ 765,208 total
  • Purchase

    Common Stock

    2013-03-25$7.00/sh+121,428$849,996→ 540,592 total
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−400,000→ 0 total
    → Common Stock (13,793 underlying)
  • Conversion

    Common Stock

    2013-03-25+27,586→ 56,321 total
  • Conversion

    Common Stock

    2013-03-25+17,991→ 46,151 total
  • Conversion

    Common Stock

    2013-03-25+35,982→ 92,303 total
  • Conversion

    Common Stock

    2013-03-25+106,776→ 152,927 total
  • Conversion

    Common Stock

    2013-03-25+313,845→ 419,164 total
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−2,132,517→ 0 total
    → Common Stock (73,555 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−2,761,571→ 0 total
    → Common Stock (95,226 underlying)
  • Conversion

    Common Stock

    2013-03-25+95,226→ 248,153 total
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−800,000→ 0 total
    → Common Stock (27,586 underlying)
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−521,739→ 0 total
    → Common Stock (17,991 underlying)
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−521,739→ 0 total
    → Common Stock (17,991 underlying)
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−1,043,478→ 0 total
    → Common Stock (35,982 underlying)
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−6,193,019→ 0 total
    → Common Stock (213,552 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−2,917,152→ 0 total
    → Common Stock (100,591 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−8,556,982→ 0 total
    → Common Stock (295,068 underlying)
Mediphase (DP&UP) LLC
10% Owner
Transactions
  • Conversion

    Common Stock

    2013-03-25+17,991→ 31,784 total
  • Conversion

    Common Stock

    2013-03-25+313,845→ 419,164 total
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−3,096,509→ 0 total
    → Common Stock (106,776 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−9,101,517→ 0 total
    → Common Stock (313,845 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−8,556,982→ 0 total
    → Common Stock (295,068 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−2,917,152→ 0 total
    → Common Stock (100,591 underlying)
  • Conversion

    Common Stock

    2013-03-25+13,793→ 13,793 total
  • Conversion

    Common Stock

    2013-03-25+73,535→ 105,319 total
  • Conversion

    Common Stock

    2013-03-25+100,591→ 100,591 total
  • Purchase

    Common Stock

    2013-03-25$7.00/sh+121,428$849,996→ 540,592 total
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−521,739→ 0 total
    → Common Stock (17,991 underlying)
  • Conversion

    Common Stock

    2013-03-25+17,991→ 46,151 total
  • Conversion

    Common Stock

    2013-03-25+106,776→ 152,927 total
  • Conversion

    Common Stock

    2013-03-25+213,552→ 305,855 total
  • Conversion

    Common Stock

    2013-03-25+295,068→ 600,923 total
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−400,000→ 0 total
    → Common Stock (13,793 underlying)
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−521,739→ 0 total
    → Common Stock (17,991 underlying)
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−2,132,517→ 0 total
    → Common Stock (73,555 underlying)
  • Conversion

    Common Stock

    2013-03-25+13,793→ 28,160 total
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−400,000→ 0 total
    → Common Stock (13,793 underlying)
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−800,000→ 0 total
    → Common Stock (27,586 underlying)
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−1,043,478→ 0 total
    → Common Stock (35,982 underlying)
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−6,193,019→ 0 total
    → Common Stock (213,552 underlying)
  • Conversion

    Common Stock

    2013-03-25+27,586→ 56,321 total
  • Conversion

    Common Stock

    2013-03-25+35,982→ 92,303 total
  • Conversion

    Common Stock

    2013-03-25+95,226→ 248,153 total
  • Purchase

    Common Stock

    2013-03-25$7.00/sh+164,285$1,149,995→ 765,208 total
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−2,761,571→ 0 total
    → Common Stock (95,226 underlying)
Mediphase II (Annex Fund) LLC
10% Owner
Transactions
  • Conversion

    Common Stock

    2013-03-25+13,793→ 13,793 total
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−800,000→ 0 total
    → Common Stock (27,586 underlying)
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−1,043,478→ 0 total
    → Common Stock (35,982 underlying)
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−3,096,509→ 0 total
    → Common Stock (106,776 underlying)
  • Conversion

    Common Stock

    2013-03-25+13,793→ 28,160 total
  • Conversion

    Common Stock

    2013-03-25+73,535→ 105,319 total
  • Conversion

    Common Stock

    2013-03-25+95,226→ 248,153 total
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−8,556,982→ 0 total
    → Common Stock (295,068 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−2,917,152→ 0 total
    → Common Stock (100,591 underlying)
  • Conversion

    Common Stock

    2013-03-25+295,068→ 600,923 total
  • Purchase

    Common Stock

    2013-03-25$7.00/sh+164,285$1,149,995→ 765,208 total
  • Purchase

    Common Stock

    2013-03-25$7.00/sh+121,428$849,996→ 540,592 total
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−400,000→ 0 total
    → Common Stock (13,793 underlying)
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−521,739→ 0 total
    → Common Stock (17,991 underlying)
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−2,132,517→ 0 total
    → Common Stock (73,555 underlying)
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−6,193,019→ 0 total
    → Common Stock (213,552 underlying)
  • Conversion

    Common Stock

    2013-03-25+213,552→ 305,855 total
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−9,101,517→ 0 total
    → Common Stock (313,845 underlying)
  • Conversion

    Common Stock

    2013-03-25+27,586→ 56,321 total
  • Conversion

    Common Stock

    2013-03-25+17,991→ 31,784 total
  • Conversion

    Common Stock

    2013-03-25+17,991→ 46,151 total
  • Conversion

    Common Stock

    2013-03-25+35,982→ 92,303 total
  • Conversion

    Common Stock

    2013-03-25+106,776→ 152,927 total
  • Conversion

    Common Stock

    2013-03-25+313,845→ 419,164 total
  • Conversion

    Common Stock

    2013-03-25+100,591→ 100,591 total
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−400,000→ 0 total
    → Common Stock (13,793 underlying)
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−521,739→ 0 total
    → Common Stock (17,991 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−2,761,571→ 0 total
    → Common Stock (95,226 underlying)
MEDIPHASE VENTURE PARTNERS II LP
Director10% Owner
Transactions
  • Conversion

    Common Stock

    2013-03-25+13,793→ 13,793 total
  • Conversion

    Common Stock

    2013-03-25+27,586→ 56,321 total
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−1,043,478→ 0 total
    → Common Stock (35,982 underlying)
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−800,000→ 0 total
    → Common Stock (27,586 underlying)
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−3,096,509→ 0 total
    → Common Stock (106,776 underlying)
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−6,193,019→ 0 total
    → Common Stock (213,552 underlying)
  • Conversion

    Common Stock

    2013-03-25+106,776→ 152,927 total
  • Conversion

    Common Stock

    2013-03-25+295,068→ 600,923 total
  • Purchase

    Common Stock

    2013-03-25$7.00/sh+164,285$1,149,995→ 765,208 total
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−400,000→ 0 total
    → Common Stock (13,793 underlying)
  • Conversion

    Common Stock

    2013-03-25+213,552→ 305,855 total
  • Conversion

    Common Stock

    2013-03-25+313,845→ 419,164 total
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−400,000→ 0 total
    → Common Stock (13,793 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−9,101,517→ 0 total
    → Common Stock (313,845 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−2,761,571→ 0 total
    → Common Stock (95,226 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−8,556,982→ 0 total
    → Common Stock (295,068 underlying)
  • Conversion

    Common Stock

    2013-03-25+13,793→ 28,160 total
  • Conversion

    Common Stock

    2013-03-25+35,982→ 92,303 total
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−521,739→ 0 total
    → Common Stock (17,991 underlying)
  • Conversion

    Common Stock

    2013-03-25+17,991→ 31,784 total
  • Conversion

    Common Stock

    2013-03-25+17,991→ 46,151 total
  • Conversion

    Common Stock

    2013-03-25+73,535→ 105,319 total
  • Conversion

    Common Stock

    2013-03-25+95,226→ 248,153 total
  • Conversion

    Common Stock

    2013-03-25+100,591→ 100,591 total
  • Purchase

    Common Stock

    2013-03-25$7.00/sh+121,428$849,996→ 540,592 total
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−521,739→ 0 total
    → Common Stock (17,991 underlying)
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−2,132,517→ 0 total
    → Common Stock (73,555 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−2,917,152→ 0 total
    → Common Stock (100,591 underlying)
Mediphase Venture Partners (DP&UP) Limited Partnership
10% Owner
Transactions
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−1,043,478→ 0 total
    → Common Stock (35,982 underlying)
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−3,096,509→ 0 total
    → Common Stock (106,776 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−8,556,982→ 0 total
    → Common Stock (295,068 underlying)
  • Conversion

    Common Stock

    2013-03-25+27,586→ 56,321 total
  • Conversion

    Common Stock

    2013-03-25+17,991→ 31,784 total
  • Conversion

    Common Stock

    2013-03-25+17,991→ 46,151 total
  • Conversion

    Common Stock

    2013-03-25+106,776→ 152,927 total
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−2,761,571→ 0 total
    → Common Stock (95,226 underlying)
  • Conversion

    Common Stock

    2013-03-25+13,793→ 28,160 total
  • Conversion

    Common Stock

    2013-03-25+73,535→ 105,319 total
  • Conversion

    Common Stock

    2013-03-25+213,552→ 305,855 total
  • Conversion

    Common Stock

    2013-03-25+95,226→ 248,153 total
  • Conversion

    Common Stock

    2013-03-25+100,591→ 100,591 total
  • Purchase

    Common Stock

    2013-03-25$7.00/sh+121,428$849,996→ 540,592 total
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−400,000→ 0 total
    → Common Stock (13,793 underlying)
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−521,739→ 0 total
    → Common Stock (17,991 underlying)
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−2,132,517→ 0 total
    → Common Stock (73,555 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−9,101,517→ 0 total
    → Common Stock (313,845 underlying)
  • Conversion

    Common Stock

    2013-03-25+35,982→ 92,303 total
  • Conversion

    Common Stock

    2013-03-25+313,845→ 419,164 total
  • Conversion

    Common Stock

    2013-03-25+295,068→ 600,923 total
  • Purchase

    Common Stock

    2013-03-25$7.00/sh+164,285$1,149,995→ 765,208 total
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−400,000→ 0 total
    → Common Stock (13,793 underlying)
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−800,000→ 0 total
    → Common Stock (27,586 underlying)
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−6,193,019→ 0 total
    → Common Stock (213,552 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−2,917,152→ 0 total
    → Common Stock (100,591 underlying)
  • Conversion

    Common Stock

    2013-03-25+13,793→ 13,793 total
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−521,739→ 0 total
    → Common Stock (17,991 underlying)
Mediphase Venture Partners II (Annex Fund) Limited Partnership
10% Owner
Transactions
  • Conversion

    Common Stock

    2013-03-25+17,991→ 31,784 total
  • Conversion

    Common Stock

    2013-03-25+95,226→ 248,153 total
  • Purchase

    Common Stock

    2013-03-25$7.00/sh+121,428$849,996→ 540,592 total
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−400,000→ 0 total
    → Common Stock (13,793 underlying)
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−800,000→ 0 total
    → Common Stock (27,586 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−2,761,571→ 0 total
    → Common Stock (95,226 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−8,556,982→ 0 total
    → Common Stock (295,068 underlying)
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−400,000→ 0 total
    → Common Stock (13,793 underlying)
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−521,739→ 0 total
    → Common Stock (17,991 underlying)
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−2,132,517→ 0 total
    → Common Stock (73,555 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−2,917,152→ 0 total
    → Common Stock (100,591 underlying)
  • Conversion

    Common Stock

    2013-03-25+17,991→ 46,151 total
  • Conversion

    Common Stock

    2013-03-25+106,776→ 152,927 total
  • Purchase

    Common Stock

    2013-03-25$7.00/sh+164,285$1,149,995→ 765,208 total
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−521,739→ 0 total
    → Common Stock (17,991 underlying)
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−3,096,509→ 0 total
    → Common Stock (106,776 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−9,101,517→ 0 total
    → Common Stock (313,845 underlying)
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−1,043,478→ 0 total
    → Common Stock (35,982 underlying)
  • Conversion

    Common Stock

    2013-03-25+13,793→ 13,793 total
  • Conversion

    Common Stock

    2013-03-25+13,793→ 28,160 total
  • Conversion

    Common Stock

    2013-03-25+27,586→ 56,321 total
  • Conversion

    Common Stock

    2013-03-25+73,535→ 105,319 total
  • Conversion

    Common Stock

    2013-03-25+213,552→ 305,855 total
  • Conversion

    Common Stock

    2013-03-25+313,845→ 419,164 total
  • Conversion

    Common Stock

    2013-03-25+295,068→ 600,923 total
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−6,193,019→ 0 total
    → Common Stock (213,552 underlying)
  • Conversion

    Common Stock

    2013-03-25+35,982→ 92,303 total
  • Conversion

    Common Stock

    2013-03-25+100,591→ 100,591 total
Miller Lawrence G.
10% Owner
Transactions
  • Conversion

    Common Stock

    2013-03-25+17,991→ 31,784 total
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−6,193,019→ 0 total
    → Common Stock (213,552 underlying)
  • Conversion

    Common Stock

    2013-03-25+35,982→ 92,303 total
  • Conversion

    Common Stock

    2013-03-25+73,535→ 105,319 total
  • Conversion

    Common Stock

    2013-03-25+106,776→ 152,927 total
  • Conversion

    Common Stock

    2013-03-25+313,845→ 419,164 total
  • Conversion

    Common Stock

    2013-03-25+95,226→ 248,153 total
  • Purchase

    Common Stock

    2013-03-25$7.00/sh+164,285$1,149,995→ 765,208 total
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−400,000→ 0 total
    → Common Stock (13,793 underlying)
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−521,739→ 0 total
    → Common Stock (17,991 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−2,917,152→ 0 total
    → Common Stock (100,591 underlying)
  • Conversion

    Common Stock

    2013-03-25+27,586→ 56,321 total
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−1,043,478→ 0 total
    → Common Stock (35,982 underlying)
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−3,096,509→ 0 total
    → Common Stock (106,776 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−9,101,517→ 0 total
    → Common Stock (313,845 underlying)
  • Conversion

    Common Stock

    2013-03-25+13,793→ 13,793 total
  • Conversion

    Common Stock

    2013-03-25+17,991→ 46,151 total
  • Conversion

    Common Stock

    2013-03-25+213,552→ 305,855 total
  • Conversion

    Common Stock

    2013-03-25+100,591→ 100,591 total
  • Purchase

    Common Stock

    2013-03-25$7.00/sh+121,428$849,996→ 540,592 total
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−2,761,571→ 0 total
    → Common Stock (95,226 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−8,556,982→ 0 total
    → Common Stock (295,068 underlying)
  • Conversion

    Common Stock

    2013-03-25+13,793→ 28,160 total
  • Conversion

    Common Stock

    2013-03-25+295,068→ 600,923 total
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−400,000→ 0 total
    → Common Stock (13,793 underlying)
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−800,000→ 0 total
    → Common Stock (27,586 underlying)
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−521,739→ 0 total
    → Common Stock (17,991 underlying)
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−2,132,517→ 0 total
    → Common Stock (73,555 underlying)
Howard Paul Anthony
10% Owner
Transactions
  • Conversion

    Common Stock

    2013-03-25+100,591→ 100,591 total
  • Purchase

    Common Stock

    2013-03-25$7.00/sh+121,428$849,996→ 540,592 total
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−3,096,509→ 0 total
    → Common Stock (106,776 underlying)
  • Conversion

    Common Stock

    2013-03-25+13,793→ 13,793 total
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−521,739→ 0 total
    → Common Stock (17,991 underlying)
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−1,043,478→ 0 total
    → Common Stock (35,982 underlying)
  • Conversion

    Common Stock

    2013-03-25+13,793→ 28,160 total
  • Conversion

    Common Stock

    2013-03-25+27,586→ 56,321 total
  • Conversion

    Common Stock

    2013-03-25+17,991→ 46,151 total
  • Conversion

    Common Stock

    2013-03-25+106,776→ 152,927 total
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−9,101,517→ 0 total
    → Common Stock (313,845 underlying)
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−400,000→ 0 total
    → Common Stock (13,793 underlying)
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−521,739→ 0 total
    → Common Stock (17,991 underlying)
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−2,132,517→ 0 total
    → Common Stock (73,555 underlying)
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−6,193,019→ 0 total
    → Common Stock (213,552 underlying)
  • Conversion

    Common Stock

    2013-03-25+73,535→ 105,319 total
  • Conversion

    Common Stock

    2013-03-25+213,552→ 305,855 total
  • Conversion

    Common Stock

    2013-03-25+95,226→ 248,153 total
  • Conversion

    Common Stock

    2013-03-25+295,068→ 600,923 total
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−800,000→ 0 total
    → Common Stock (27,586 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−8,556,982→ 0 total
    → Common Stock (295,068 underlying)
  • Conversion

    Common Stock

    2013-03-25+17,991→ 31,784 total
  • Conversion

    Common Stock

    2013-03-25+35,982→ 92,303 total
  • Conversion

    Common Stock

    2013-03-25+313,845→ 419,164 total
  • Purchase

    Common Stock

    2013-03-25$7.00/sh+164,285$1,149,995→ 765,208 total
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−400,000→ 0 total
    → Common Stock (13,793 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−2,761,571→ 0 total
    → Common Stock (95,226 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−2,917,152→ 0 total
    → Common Stock (100,591 underlying)
Mediphase II (Select Fund) LLC
10% Owner
Transactions
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−6,193,019→ 0 total
    → Common Stock (213,552 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−9,101,517→ 0 total
    → Common Stock (313,845 underlying)
  • Conversion

    Common Stock

    2013-03-25+27,586→ 56,321 total
  • Conversion

    Common Stock

    2013-03-25+17,991→ 46,151 total
  • Conversion

    Common Stock

    2013-03-25+106,776→ 152,927 total
  • Conversion

    Common Stock

    2013-03-25+313,845→ 419,164 total
  • Conversion

    Common Stock

    2013-03-25+295,068→ 600,923 total
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−400,000→ 0 total
    → Common Stock (13,793 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−2,761,571→ 0 total
    → Common Stock (95,226 underlying)
  • Conversion

    Common Stock

    2013-03-25+13,793→ 13,793 total
  • Conversion

    Common Stock

    2013-03-25+13,793→ 28,160 total
  • Conversion

    Common Stock

    2013-03-25+35,982→ 92,303 total
  • Conversion

    Common Stock

    2013-03-25+95,226→ 248,153 total
  • Purchase

    Common Stock

    2013-03-25$7.00/sh+121,428$849,996→ 540,592 total
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−2,132,517→ 0 total
    → Common Stock (73,555 underlying)
  • Conversion

    Common Stock

    2013-03-25+73,535→ 105,319 total
  • Conversion

    Common Stock

    2013-03-25+213,552→ 305,855 total
  • Conversion

    Common Stock

    2013-03-25+100,591→ 100,591 total
  • Purchase

    Common Stock

    2013-03-25$7.00/sh+164,285$1,149,995→ 765,208 total
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−400,000→ 0 total
    → Common Stock (13,793 underlying)
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−521,739→ 0 total
    → Common Stock (17,991 underlying)
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−1,043,478→ 0 total
    → Common Stock (35,982 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−8,556,982→ 0 total
    → Common Stock (295,068 underlying)
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-25−2,917,152→ 0 total
    → Common Stock (100,591 underlying)
  • Conversion

    Series B Convertible Participating Preferred Stock

    2013-03-25−3,096,509→ 0 total
    → Common Stock (106,776 underlying)
  • Conversion

    Common Stock

    2013-03-25+17,991→ 31,784 total
  • Conversion

    Series A-1 Convertible Participating Preferred Stock

    2013-03-25−800,000→ 0 total
    → Common Stock (27,586 underlying)
  • Conversion

    Series A-2 Convertible Participating Preferred Stock

    2013-03-25−521,739→ 0 total
    → Common Stock (17,991 underlying)
Footnotes (6)
  • [F1]The Series A-1, Series A-2, Series B and Series C Convertible Preferred Stock converted into Common Stock on a 1-for-29 basis upon the closing of the issuer's initial public offering without payment of consideration.
  • [F2]These securities are held solely by Mediphase Venture Partners (DP & UP) Limited Partnership. Mediphase Venture Partners (DP & UP) LLC is the general partner of Mediphase Venture Partners (DP & UP) Limited Partnership. The members of Mediphase(DP & UP) LLC are Lawrence Miller and Paul Howard. Mediphase(DP & UP) LLC and each of these individuals exercises shared voting and investment power over the shares held of record by Mediphase Venture Partners (DP & UP) Limited Partnership. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
  • [F3]These securities are held solely by Mediphase Venture Partners II (Annex Fund) Limited Partnership. Mediphase II (Annex Fund) LLC is the general partner of Mediphase Venture Partners II (Annex Fund) Limited Partnership. The members of Mediphase II (Annex Fund) LLC are Lawrence Miller and Paul Howard. Mediphase II (Annex Fund) LLC and each of these individuals exercises shared voting and investment power over the shares held of record by Mediphase Venture Partners II (Annex Fund) Limited Partnership. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
  • [F4]These securities are held solely by Mediphase Venture Partners II Limited Partnership. Mediphase II LLC is the general partner of Mediphase Venture Partners II Limited Partnership. The members of Mediphase II LLC are Lawrence Miller and Paul Howard. Mediphase II LLC and each of these individuals exercises shared voting and investment power over the shares held of record by Mediphase Venture Partners II Limited Partnership. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
  • [F5]These securities are held solely by Mediphase II (Select Fund) Limited Partnership. Mediphase II (Select Fund) LLC is the general partner of Mediphase Venture Partners II (Select Fund) L.P. The members of Mediphase II (Select Fund) LLC are Lawrence Miller and Paul Howard. Mediphase II (Select Fund) LLC and each of these individuals exercises shared voting and investment power over the shares held of record by Mediphase Venture Partners II (Select Fund) L.P. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
  • [F6]Not Applicable

Documents

1 file

Issuer

TETRAPHASE PHARMACEUTICALS INC

CIK 0001373707

→
Entity typeother

Related Parties

1
  • filerCIK 0001164374

Filing Metadata

Form type
4
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 8:15 PM ET
Size
69.0 KB
View on SEC.gov